---
title: Clario vs ICON
slug_a: clario
slug_b: kcrcro
site: cro
review_signal_gate: closed
canonical_path: /compare/clario/kcrcro
generated_by: BioBM Editorial AI
---

# Clario vs ICON

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clario (clario) is listed for cro. Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Services: 16. Modalities: 4. Indications: 12. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (16).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

ICON (kcrcro) is listed for cro. ICON is a CRO with 8,000 biotech-dedicated professionals offering end-to-end clinical development, consulting, and therapeutic expertise across all development phases.

Services: 22. Modalities: 5. Indications: 7. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (22).

Review summary: Review summary withheld until site-level review gate opens.